Genetic abnormalities involved in the pathogenesis of gallbladder carcinoma

Journal of Hepato-Biliary-Pancreatic Surgery

Volumn 6, Issue 3, 1999, Pages 237-244

  Wistuba, Ignacio I ^a,c   Albores Saavedra, Jorge ^b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Gallbladder carcinoma; Genetic mutation; p53 and K ras genes

Indexed keywords

ADENOCARCINOMA; FEMALE; GALLBLADDER TUMOR; GENE EXPRESSION; GENETIC PREDISPOSITION; GENETICS; HUMAN; MALE; MUTATION; ONCOGENE RAS; PATHOLOGY; REVIEW; SENSITIVITY AND SPECIFICITY; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; FEMALE; GALLBLADDER NEOPLASMS; GENE EXPRESSION; GENES, P53; GENES, RAS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MUTATION; SENSITIVITY AND SPECIFICITY;

EID: 0033286023     PISSN: 09441166     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005340050113     Document Type: Article

References (85)

1. Albores-Saavedra J, Klimstra D, Henson DE (1999) Tumors of gallbladder, extrahepatic bile ducts and ampulla of vater. Fascicle 23, 3rd edn. Armed Forces Institute of Pathology, Washington, DC. (In press)
2. Tavani A, Negri E, La Vecchia C (1996) Biliary tract tumors. Ann Ist Super Sanita 32:615-619
3. Serra I, Calvo A, Maturana M, Medina E, Sharp A (1990) Changing trends of gall-bladder cancer in Chile, a high-risk area. Int J Cancer 45:376-377
4. Ministry of Health and Welfare (1996) Vital statistics of Japan. Health and Welfare Statistical Association, Tokyo
5. Knudson AG (1989) Hereditary cancers: clues to mechanisms of carcinogenesis. Br J Cancer 59:661-666
6. Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N, Perucho M (1988) Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 53:549-554
7. Tada M, Yokosuka O, Omata M, Ohio M, Isono K (1990) Analysis of ras gene mutations in biliary and pancreatic tumors by polymerase chain reaction and direct sequencing. Cancer 66:930-935
8. Yoshida S, Todoroki T, Ichikawa Y, Hanai S, Suzuki H, Hori M, Fukao K, Miwa M, Uchida K (1995) Mutations of p16Ink4/ CDKN2 and p15Ink4B/MTS2 genes in biliary tract cancers. Cancer Res 55:2756-2760
9. Imai M, Hoshi T, Ogawa K (1994) K-ras codon 12 mutations in biliary tract tumors detected by polymerase chain reaction denaturing gradient gel electrophoresis. Cancer 73:2727-2733
10. Wistuba II, Sugio KHJ, Kishimoto Y, Virmani AK, Roa I, Albores-Saavedra J, Gazdar AF (1995) Allele specific mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile. Cancer Res 55:2511-2515
11. Saetta A, Lazaris AC, Davaris PS (1996) Detection of ras oncogene point mutations and simultaneous proliferative fraction estimation in gallbladder cancer. Pathol Res Pract 192:532-540
12. Hanada K, Itoh M, Fujii K, Tsuchida A, Ooishi H, Kajiyama G (1996) K-ras and p53 mutations in stage I gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct. Cancer 77:452-458
13. Matsubara T, Sakurai Y, Sasayama Y, Hori H, Ochiai M, Funabiki T, Matsumoto K, Hirono I (1996) K-ras point mutations in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction. Cancer 77:1752-1757
14. Tomono H, Nimura Y, Aono K, Nakashima I, Iwamoto T, Nakashima N (1996) Point mutations of the c-Ki-ras gene in carcinoma and atypical epithelium associated with congenital biliary dilation. Am J Gastroenterol 91:1211-1214
15. Iwase T, Nakazawa S, Yamao K, Yoshino J, Inui K, Yamachika H, Kanemaki N, Fujimoto M, Okushima K, Miyoshi H, Taki N, Nakamura Y, Mizutani S, Horibe Y, Masui T, Tatematsu M (1997) Ras gene point mutations in gallbladder lesions associated with anomalous connection of pancreatobiliary ducts. Hepatogastroenterology 44:1457-1462
16. Tanno S, Obara T, Fujii T, Mizukami Y, Shudo R, Nishino N, Ura H, Klein-Szanto AJ, Kohgo Y (1998) Proliferative potential and K-ras mutation in epithelial hyperplasia of the gallbladder in patients with anomalous pancreaticobiliary ductal union. Cancer 83:267-275
17. Barbacid M (1987) ras genes. Annu Rev Biochem 56:779-827
18. Wittinghofer A, Scheffzek K, Ahmadian MR (1997) The interaction of Ras with GTPase-activating proteins. FEBS Lett 410:63-67
19. Bos JL (1988) The ras gene family and human carcinogenesis. Mutat Res 195:255-271
20. Komi N, Udaka H, Ikeda N, Kashiwagi Y (1977) Congenital dilatation of the biliary tract: new classification and study with particular reference to anomalous arrangement of the pancreaticobiliary ducts. Gastroenterol Jpn 12:293-304
21. Kimura K, Ohio M, Saisho H, Unozawa T, Tsuchiya Y, Morita M, Ebara M, Matsutani S, Okuda K (1985) Association of gallbladder carcinoma and anomalous pancreaticobiliary ductal union. Gastroenterology 89:1258-1265
22. Kinoshita H, Nagata E, Hirohashi K, Sakai K, Kobayashi Y (1984) Carcinoma of the gallbladder with an anomalous connection between the choledochus and the pancreatic duct. Report of ten cases and review of the literature in Japan. Cancer 54:762-769
23. Yamauchi S, Koga A, Matsumoto S, Tanaka M, Nakayama F (1987) Anomalous junction of pancreaticobiliary duct without congenital choledochal cyst: a possible risk factor for gallbladder cancer. Am J Gastroenterol 82:20-24
24. Neiderhiser DH, Morningstar WA, Roth HP (1973) Absorption of lecithin and lysolecithin by the gallbladder. J Lab Clin Med 82:891-897
25. Yamamoto M, Nakajo S, Tahara E, Ito M, Taniyama K, Shimamoto F, Miyoshi N, Hayashi Y, Akiyama H, Nakai S (1991) Mucosal changes of the gallbladder in anomalous union with the pancreatico-biliary duct system. Pathol Res Pract 187:241-246
26. Smit VT, Boot AJ, Smits AM, Fleuren GJ, Cornelisse CJ, Bos JL (1988) KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas. Nucleic Acids Res 16:7773-7782
27. Grunewald K, Lyons J, Frohlich A, Feichtinger H, Weger RA, Schwab G, Janssen JW, Bartram CR (1989) High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinomas. Int J Cancer 43:1037-1041
28. Levine AJ (1997) p53, the cellular gatekeeper for growth and division. Cell 88:323-331
29. Vogelstein B, Kinzler KW (1992) p53 function and dysfunction. Cell 70:523-526
30. Greenblatt MS, Bennett WP, Hollatein M, Harris CC (1994) Mutations in the p53 tumor supressor gene: clue to cancer etiology and molecular pathogenesis. Cancer Res 54:4855-4878
31. Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991) p53 mutations in human cancers. Science 253:49-53
32. Bartek J, Bartkov:a J, Vojt:esek B, Sta:skov:a Z, Lukas J, Rejthar A, Kovarik J, Midgley CA, Gannon JV, Lane DP (1991) Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies. Oncogene 6:1699-1703
33. Kamel D, Paakko P, Nuorva K, Vahakangas K, Soini Y (1993) p53 and c-erbB-2 protein expression in adenocarcinomas and epithelial dysplasias of the gall bladder. J Pathol 170:67-72
34. Teh M, Wee A, Raju GC (1994) An immunohistochemical study of p53 protein in gallbladder and extrahepatic bile duct/ampullary carcinomas. Cancer 74:1542-1545
35. Takagi S, Naito E, Yamanouchi H, Ohtsuka H, Kominami R, Yamamoto M (1994) Mutation of the p53 gene in gallbladder cancer. Tohoku J Exp Med 172:283-289
36. Wee A, Teh M, Raju GC (1994) Clinical importance of p53 protein in gall bladder carcinoma and its precursor lesions. J Clin Pathol 47:453-456
37. Lee CS, Pirdas A (1995) p53 protein immunoreactivity in cancers of the gallbladder, extrahepatic bile ducts and ampulla of Vater. Pathology 27:117-120
38. Oohashi Y, Watanabe H, Ajioka Y, Hatakeyama K (1995) p53 immunostaining distinguishes malignant from benign lesions of the gall-bladder. Pathol Int 45:58-65
39. Diamantis I, Karamitopoulou E, Perentes E, Zimmermann A (1995) p53 protein immunoreactivity in extrahepatic bile duct and gallbladder cancer: correlation with tumor grade and survival. Hepatology 22:774-779
40. Fujii K, Yokozaki H, Yasui W, Kuniyasu H, Hirata M, Kajiyama G, Tahara E (1996) High frequency of p53 gene mutation in adenocarcinomas of the gallbladder. Cancer Epidemiol Biomarkers Prev 5:461-466
41. Wistuba II, Gazdar AF, Roa I, Albores-Saavedra J (1996) p53 protein overexpression in gallbladder carcinoma and its precursor lesions: an immunohistochemical study. Hum Pathol 27:360-365
42. Sasatomi E, Tokunaga O, Miyazaki K (1996) Spontaneous apoptosis in gallbladder carcinoma. Relationships with clinicopathologic factors, expression of E-cadherin, bcl-2 protooncogene, and p53 oncosuppressor gene. Cancer 78:2101-2110
43. Takei K, Watanabe H, Itoi T, Saito T (1996) p53 and Ki-67 immunoreactivity and nuclear morphometry of "carcinoma-in-adenoma" and adenoma of the gall-bladder. Pathol Int 46:908-917
44. Washington K, Gottfried MR (1996) Expression of p53 in adenocarcinoma of the gallbladder and bile ducts. Liver 16:99-104
45. Ajiki T, Onoyama H, Yamamoto M, Asaka K, Fujimori T, Maeda S, Saitoh Y (1996) p53 protein expression and prognosis in gallbladder carcinoma and premalignant lesions. Hepatogastroenterology 43:521-526
46. Itoi T, Watanabe H, Ajioka Y, Oohashi Y, Takel K, Nishikura K, Nakamura Y, Horil A, Saito T (1996) APC, K-ras codon 12 mutations and p53 gene expression in carcinoma and adenoma of the gall-bladder suggest two genetic pathways in gallbladder carcinogenesis. Pathol Int 46:333-340
47. Kanada K, Itoh M, Fujii K, Tsuchida A, Hirata M, Iwao T, Eguchi N, Sasaki T, Matsubara K, Kajiyama G (1997) TP53 mutations in stage I gallbladder carcinoma with special attention to growth patterns. Eur J Cancer 33:1136-1140
48. Roa I, Villaseca M, Araya J, Roa J, de Aretxabala X, Melo A, Ibacache G (1997) p53 tumour suppressor gene protein expression in early and advanced gallbladder carcinoma. Histopathology 31:226-230
49. Roa I, Villaseca M, Araya JC, Roa J, de Aretxabala X, Fuentealba P, Melo A (1997) DNA ploidy pattern and tumor suppressor gene p53 expression in gallbladder carcinoma. Cancer Epidemiol Biomarkers Prev 6:547-550
50. Itoi T, Watanabe H, Yoshida M, Ajioka Y, Nishikura K, Saito T (1997) Correlation of p53 protein expression with gene mutation in gall-bladder carcinomas. Pathol Int 47:525-530
51. Jonas S, Springmeier G, Tauber R, Wiedenmann B, Gessner R, Kling N, Lobeck H, Fieger C, Bechstein WO, Neuhaus P (1997) p53 hot-spot mutational analysis in advanced Western gallbladder carcinoma. World J Surg 21:768-772
52. Yokoyama N, Hitomi J, Watanabe H, Ajioka Y, Pruyas M, Serra I, Shirai Y, Hatakeyama K (1998) Mutations of p53 in gallbladder carcinomas in high-incidence areas of Japan and Chile. Cancer Epidemiol Biomarkers Prev 7:297-301
53. Casey G, Lopez ME, Ramos JC, Plummer SJ, Arboleda MJ, Shaughnessy M, Karlan B, Slamon DJ (1996) DNA sequence analysis of exons 2 through 11 and immunohistochemical staining are required to detect all known p53 alterations in human malignancies. Oncogene 13:1971-1981
54. Kennedy SM, Macgeogh C, Jaffe R, Spurr NK (1994) Overexpression of the oncoprotein p53 in primary hepatic tumors of childhood does not correlate with gene mutations. Hum Pathol 25:438-442
55. Cesarman E, Inghirami G, Chadburn A, Knowles DM (1993) High levels of p53 protein expression do not correlate with p53 gene mutations in anaplastic large cell lymphoma. Am J Pathol 143:845-856
56. Matsushima AY, Cesarman E, Chadburn A, Knowles DM (1994) Post-thymic T cell lymphomas frequently overexpress p53 protein but infrequently exhibit p53 gene mutations. Am J Pathol 144: 573-584
57. Wagata T, Shibagaki I, Imamura M, Shimada Y, Toguchida J, Yandell DW, Ikenaga M, Tobe T, Ishizaki K (1993) Loss of 17p, mutation of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas. Cancer Res 53:846-850
58. Esrig D, Spruck CD, Nichols PW, Chaiwun B, Steven K, Groshen S, Chen SC, Skinner DG, Jones PA, Cote RJ (1993) p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. Am J Pathol 143:1389-1397
59. Scarpa A, Capelli P, Mukai K, Zamboni G, Oda T, Iacono C, Hirohashi S (1993) Pancreatic adenocarcinomas frequently show p53 gene mutations. Am J Pathol 142:1534-1543
60. Jones PA, Buckley JD, Henderson BE, Ross RK, Pike MC (1991) From gene to carcinogen: a rapidly evolving field in molecular epidemiology. Cancer Res 51:3617-3620
61. Rideout WMD, Coetzee GA, Olumi AF, Jones PA (1990) 5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. Science 249:1288-1290
62. Harris CC (1996) The 1995 Walter Hubert Lecture -molecular epidemiology of human cancer: insights from the mutational analysis of the p53 tumour-suppressor gene. Br J Cancer 73:261-269
63. Olopade OI, Buchhagen DL, Minna JD, Gazdar AF, Malik KC, Rowley JD, Diaz MO (1991) Deletions of the short arm of chromosome 9 that include the alpha and beta interferon genes are associated with lung cancers (abstract). Proc Annu Meet Am Assoc Cancer Res 32:1814
64. Olopade OI, Buchhagen DL, Malik K, Sherman J, Nobori T, Bader S, Nau MM, Gazdar AF, Minna JD, Diaz MO (1993) Homozygous loss of the interferon genes defines the critical region on 9p that is deleted in lung cancers. Cancer Res 53 (10 Suppl):2410-2415
65. Kamb A, Shattuck-Eidens D, Eeles R, Liu Q, Gruis NA, Ding W, Hussey C, Tran T, Miki Y, Weaver-Feldhaus J, McLure M, Aitken JF, Anderson DE, Bergman W, Frants R, Goldgar DE, Green A, MacLennan R, Martin NG, Meyer LJ, Youl P, Zone JJ, Skolnick MH, Cannon-Albright LA (1994) Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat Genet 8:22-26
66. Hannon GJ, Beach D (1994) p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature 371:257-261
67. Fujiwara Y, Ohata H, Emi M, Okui K, Koyama K, Tsuchiya E, Nakajima T, Monden M, Mori T, Kurimasa A, Nakamura Y (1994) A 3-Mb physical map of the chromosome region 8p21.3-p22, including a 600-kb region commonly deleted in human hepatocellular carcinoma, colorectal cancer, and non-small cell lung cancer. Genes Chromosom Cancer 10:7-14
68. Fearon ER, Cho KR, Nigro JM, Kern SE, Simons JW, Ruppert JM, Hamilton SR, Preisinger AC, Thomas G, Kinzler KW, Vogelstein B (1990) Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 247:49-56
69. Nishisho I, Nakamura Y, Miyoshi Y, Miki Y, Ando H, Horii A, Koyama K, Utsunomiya J, Baba S, Hedge P (1991) Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 253:665-669
70. Levine AJ, Momand J (1990) Tumor suppressor genes: the p53 and retinoblastoma sensitivity genes and gene products. Biochim Biophys Acta 1032:119-136
71. Wistuba II, Montellano FD, Milchgrub S, Virmani AK, Behrens C, Chen H, Ahmadian M, Nowak JA, Muller C, Minna JD, Gazdar AF (1997) Deletions of chromosome 3p are frequent and early events in the pathogenesis of uterine cervical carcinoma. Cancer Res 57:3154-3158
72. Devilee P, van den Broek M, Kuipers-Dijkshoorn N, Kolluri R, Khan PM, Pearson PL, Cornelisse CJ (1989) At least four different chromosomal regions are involved in loss of heterozygosity in human breast carcinoma. Genomics 5:554-560
73. Minna JD, Sekido Y, Fong K, Gazdar AF (1997) Molecular biology of lung cancer. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology, 5th edn. Lippincott, Philadelphia, pp 849-857
74. Albores-Saavedra J, Alcantra-Vazquez A, Cruz-Ortiz H, Herrera-Goepfert R (1980) The precursor lesions of invasive gallbladder carcinoma. Hyperplasia, atypical hyperplasia and carcinoma in situ. Cancer 45:919-927
75. Albores-Saavedra J, Henson DE, Sobin LH (1992) The WHO histological classification of tumors of the gallbladder and extrahepatic bile ducts. A commentary on the second edition. Cancer 70:410-414
76. Wistuba II, Miquel JF, Gazdar AF, Albores-Saavedra J (1999) Gallbladder adenomas have molecular abnormalities different from those present in gallbladder carcinomas. Hum Pathol 30:21-25
77. Wistuba II, Behrens C, Milchgrub S, Bryant D, Hung J, Minna JD, Gazdar AF (1999) Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma. Oncogene (In press)
78. Vogelstein B, Kinzler KW (1993) The multistep nature of cancer. Trends Genet 9:138-141
79. Smith HS (1994) Tumor-suppressor genes in breast cancer progression. Cancer Treat Res 71:79-96
80. O'Connell P, Pekkel V, Fuqua SA, Osborne CK, Clark GM, Allred DC (1998) Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci. J Natl Cancer Inst 90:697-703
81. Ajiki T, Fujimori T, Onoyama H, Yamamoto M, Kitazawa S, Maeda S, Saitoh Y (1996) K-ras gene mutation in gall bladder carcinomas and dysplasia. Gut 38:426-429
82. Kijima H, Watanabe H, Iwafuchi M, Ishihara N (1989) Histogenesis of gallbladder carcinoma from investigation of early carcinoma and microcarcinoma. Acta Pathol Jpn 39:235-244
83. Kozuka S, Tsubone N, Yasui A, Hachisuka K (1982) Relation of adenoma to carcinoma in the gallbladder. Cancer 50:2226-2234
84. Albores-Saavedra J, Vardaman CJ, Vuitch F (1993) Non-neoplastic polypoid lesions and adenomas of the gallbladder. Pathol Annu 28 Pt 1:145-177
85. Watanabe M, Asaka M, Tanaka J, Kurosawa M, Kasai M, Miyazaki T (1994) Point mutation of K-ras gene codon 12 in biliary tract tumors. Gastroenterology 107:1147-1153